Protective effect of quercetin on alcohol abstinence-induced anxiety and convulsions

Journal of Medicinal Food

Volumn 8, Issue 3, 2005, Pages 392-396

  Joshi, D ^a   Naidu, P S ^a   Singh, A ^a   Kulkarni, S K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Anxiety; Dependence; Ethanol; Locomotor Activity; Pentylenetetrazole; Quercetin; Withdrawal

Indexed keywords

ALCOHOL; PENTETRAZOLE; QUERCETIN;

ALCOHOL WITHDRAWAL; ALCOHOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; CONVULSION; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; EXPERIMENTAL TEST; FEMALE; LOCOMOTION; MALE; MIRRORED CHAMBER TEST; MORTALITY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTECTION;

ALCOHOL WITHDRAWAL SEIZURES; ANIMALS; ANXIETY; ETHANOL; FEMALE; HYPERKINESIS; MALE; MICE; MOTOR ACTIVITY; PENTYLENETETRAZOLE; QUERCETIN; SEIZURES; SUBSTANCE WITHDRAWAL SYNDROME;

ANIMALIA;

EID: 27144438213     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2005.8.392     Document Type: Article

References (23)

1. Little HJ: Mechanisms that may underlie the behavioral effects of ethanol. Prog Neurobiol 1991;36:171-194.
2. Tabakoff B, Rothstein JD: Medical and Social Aspects of Alcohol Abuse. Plenum Press, New York, 1983.
3. Parale MP, Kulkarni SK: Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats. Psychopharmacology (Berl) 1986;88:237-239.
4. Kulkarni SK: Clonidine and abstinence syndrome. Drugs Today 1988;24:411-419.
5. Miller AL: Antioxidant flavonoids: Structure, function and clinical usage. Altern Med Rev 1996;1:103-111.
6. Saija A, Scalese M, Lanza M, Marzullo D, Bonina F, Castelli F: Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radic Biol Med 1995;19: 481-486.
7. de Whalley CV, Rankin SM, Hoult JR, Jessup W, Leake DS: Flavonoids inhibit the oxidative modification of low-density lipoproteins. Biochem Pharmacol 1990;39:1743-1749.
8. Kaul TN, Middleton E Jr, Ogra PL: Antiviral effect of flavonoids on human viruses. J Med Virol 1985;15:71-79.
9. Bronner C, Landry Y: Kinetics of the inhibitory effect of flavonoids on histamine secretion from mast cells. Agents Actions 1985;16:147-151.
10. Cappaso A, Piacente S, Pizza C, Sorrentino L: Flavonoids reduce morphine withdrawal in-vitro. J Pharm Pharmacol 1998;50: 561-564.
11. Singh A, Naidu PS, Kulkarni SK: Quercetin, a bioflavonoid, reverses development of tolerance and dependence to morphine. Drug Dev Rev 2002;51:1-6.
12. Toubas PL, Abla RA, Cao W, Logen LG, Scale TW: Latency to enter a mirrored chamber: A novel behavioral assay for anxiolytic agents. Pharmacol Biochem Behav 1990;35:121-126.
13. Kulkarni SK, Reddy DS: Animal behavioral models for testing antianxiety agents. Methods Find Exp Clin Pharmacol 1996;18: 219-230.
14. Kulkarni SK, Verma A: Protective effect of BR-16A (Mental®), a herbal preparation on alcohol abstinence-induced anxiety and convulsions. Indian J Exp Biol 1993;31:435-439.
15. Hunt WA: The effect of ethanol on GABAergic transmission. Neurosci Biobehav Rev 1983;7:87-95.
16. Ticku MK, Kulkarni SK: Molecular interactions of ethanol with GABAergic system and potential of RO15-4513 as an ethanol antagonist. Pharmacol Biochem Behav 1988;30:501-510.
17. Suzdak PD, Glowa JR, Crawley JN, Schwartz RD, Skolnick P, Paul SM: A selective imidazobenzodiazepine antagonist of ethanol in the rat. Science 1986;234:1243-1247.
18. Allan AM, Harris RA: Acute and chronic ethanol treatments alter GABA receptor-operated chloride channels. Pharmacol Biochem Behav 1987;27:665-670.
19. Mehta AK, Ticku MK: Ethanol potentiation of GABAergic transmission in cultured spinal cord neurons involves gamma-aminobutyric acidA-gated chloride channels. J Pharmacol Exp Ther 1988;246:558-564.
20. Mehta AK, Ticku MK: Chronic ethanol treatment alters the behavioral effects of Ro 15-4513, a partially negative ligand for benzodiazepine binding sites. Brain Res 1989;489:93-100.
21. Fiorani M, De Sanctis R, Menghinello P, Cucchiarini L, Cellini B, Dacha M: Quercetin prevents glutathione depletion induced by dehydroascorbic acid in rabbit red blood cells. Free Radic Res 2001;34:639-648.
22. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R: Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A. Life Sci 2001;68: 921-931.
23. Bastianetto S, Zheng WH, Quirion R: Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide-related toxicity in cultured hippocampal neurons. Br J Pharmacol 2000;131:711-720.